Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by life_of_danon Feb 05, 2014 5:25pm
242 Views
Post# 22176815

RE:RE:RE:RE:marketing !

RE:RE:RE:RE:marketing !
Exactly like, throw it at the wall and see what will stick…….haven’t heard that since my dear ole de-parted pappy uttered his final words The Aura is a tough sell right now ( I’m assuming) with no billing code and some Derms believing they can do an equal job with the naked eye. If Mr. B can turn a buck without a lot of retooling, it’s great. If the guy to the left doesn’t buy it, sell it to the guy on the right. The idea of selling into research may not even be a recent idea. Verisante may have been obligated by the BC cancer agency to satisfy a quota before moving on to other sales tributaries.
Bullboard Posts